Autism: Patient-reported outcomes
Patient-reported outcomes after stem cell therapy for Autism, based on 103 patients in our follow-up registry.
Updated ·
Overall patient-reported outcomes
Physical condition
reported physical improvement
53%
N = 93
Quality of life
reported quality-of-life improvement
59%
N = 96
Treatment satisfaction
satisfied with the treatment outcome
57%
N = 101
Reported change vs. before treatment
Worse No change Small Moderate Significant
| Symptom | Reported change vs. before treatment | Reported improvement |
|---|---|---|
| Uses eye contact | | 78% |
| Responding to commands | | 73% |
| Aware of environment | | 70% |
| Interaction with others | | 69% |
| Concentration | | 69% |
| General mood | | 67% |
| Cooperation with others | | 66% |
| Expressing own needs | | 65% |
| Sleep disturbance | | 58% |
| Interest in others | | 56% |
| Comfortable with physical contact | | 55% |
| Temper tantrums | | 54% |
| Plays appropriately | | 53% |
| Using more than one word at a time | | 53% |
| Hyperactivity | | 52% |
| Uses greetings | | 50% |
| Aware of danger | | 47% |
| Dressing himself/herself | | 47% |
About this data
Patients self-assess each symptom on a 5-point scale (Worse / No improvement / Small / Moderate / Significant) at follow-up checkpoints after treatment, comparing to their pre-treatment baseline. "Reported improvement" combines the small, moderate and significant buckets. Data is updated daily from our internal patient registry. As with any medical treatment, past results do not guarantee future outcomes — improvements vary from patient to patient.
